Gentamicin Injection 40 mg/mL

Here’s the detailed profile for Gentamicin Injection 40 mg/mL πŸ‘‡


πŸ’‰ Gentamicin Injection 40 mg/mL


πŸ“˜ Description:

  • Gentamicin is a potent aminoglycoside antibiotic.
  • Supplied as solution for injection (40 mg/mL) in ampoules/vials.
  • Mechanism of action: Binds to the 30S ribosomal subunit, interfering with protein synthesis and causing misreading of mRNA β†’ bactericidal effect.
  • Effective against aerobic Gram-negative bacilli and some Gram-positive bacteria (in combination therapy).

πŸ“„ Prescription / Indications:

Used in serious bacterial infections, including:

  • Septicemia and bacteremia
  • Severe respiratory tract infections (hospital-acquired pneumonia)
  • Urinary tract infections (complicated, resistant cases)
  • Intra-abdominal infections (often with metronidazole/Ξ²-lactams)
  • Meningitis (neonatal/infant) – in combination therapy
  • Endocarditis (with ampicillin, penicillin, or vancomycin for synergy)
  • Skin, bone, and soft tissue infections
  • Prophylaxis in surgical procedures (selected cases)

🌿 Nature / Drug Class:

  • Antibiotic – Aminoglycoside
  • Concentration-dependent bactericidal activity
  • Has a post-antibiotic effect against Gram-negative organisms

βœ… Advantages:

  • Highly effective in life-threatening Gram-negative infections
  • Synergistic with Ξ²-lactams or glycopeptides against Gram-positive organisms (esp. enterococci)
  • Useful for neonatal sepsis and nosocomial infections
  • The 40 mg/mL strength is commonly used in adults and hospital settings (more practical for dosing than 10 mg/mL)

⚠️ Precautions:

Contraindications:

  • Allergy to aminoglycosides

Cautions:

  • Narrow therapeutic window β†’ requires careful dosing and monitoring
  • Renal impairment – dose adjustment mandatory
  • Avoid long-term use (↑ toxicity risk)
  • Avoid with other nephrotoxic/ototoxic drugs (vancomycin, amphotericin B, cisplatin, loop diuretics)

Adverse Effects:

  • Nephrotoxicity (reversible if detected early)
  • Ototoxicity – auditory & vestibular damage (may be irreversible)
  • Neuromuscular blockade (rare; worsens myasthenia gravis)
  • Local pain/irritation at injection site

πŸ“¦ Common Packaging:

  • Ampoules/vials containing 2 mL or 10 mL solution (40 mg/mL concentration)
  • Hospital packs also available

πŸ’‰ Administration:

  • Intramuscular (IM) injection
  • Intravenous (IV) slow injection or infusion (over 30–60 minutes)
  • Dosage based on:
    • Body weight (mg/kg)
    • Infection severity
    • Renal function
  • Therapeutic drug monitoring (TDM) strongly recommended (peak & trough levels)

❄️ Storage Conditions:

  • Store at 15–25Β°C
  • Protect from light
  • Do not freeze

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button